Alyeska Investment Group
LUNG icon

Alyeska Investment Group’s Pulmonx LUNG Stock Holding History

Alyeska Investment Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-84,891
Closed -$5.86M – 790
2020
Q4 		$5.86M Buy
+84,891
New +$4.16M 0.08% 250

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

Alyeska Investment Group's LUNG Position: Q1 2021 in Review

Alyeska Investment Group sold out of Pulmonx (LUNG) in Q1 2021, closing a stake of 84,891 shares — an estimated $5.86M sold.

Alyeska Investment Group first reported a position in LUNG in Q4 2020 and held it in 1 quarter. The position peaked at $5.86M in Q4 2020. 110 funds tracked by Wall St. Rank hold LUNG as of Q1 2021.

  • Alyeska Investment Group reported no remaining Pulmonx position as of Q1 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 84,891 Pulmonx shares in Q1 2021, an estimated $5.86M.
  • Alyeska Investment Group first reported a position in Pulmonx in Q4 2020 and held it in 1 quarter.
  • Alyeska Investment Group's Pulmonx position peaked at $5.86M in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Pulmonx as of Q1 2021.

Based on Alyeska Investment Group's 13F filing for Q1 2021, filed 17 May 2021.